Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Nov, 9 2025
Oct, 4 2025
Mar, 21 2025
Dec, 24 2025
Dec, 4 2025